US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

ホーム
投資
株式
オーストラリア
ASX
Astral Resources NL (AARO) 銘柄情報

Astral Resources NL (AARO)

0.081

0.00

(0.00%)

終了 6月12日 3:00PM

Astral Resources NL (AARO) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

0.081

( - )

買値

0.085

売値

0.095

出来高

0.00

0.00 日の範囲 0.00

0.00 52 週間の範囲 0.00

時価総額

前日終値

0.081

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

AUD 6,913,664

発行済株式数

1,801,045,606

配当利回り

PER

-61.7

1 株当たり利益 (EPS)

-0

歳入

-

純利益

-3.04M

Astral Resources NL engages in the exploration and evaluation of gold properties in Western Australia. The company’s flagship property is the 100% owned Mandilla Gold project located in the northern Widgiemooltha greenstone belt in Western Australia. The company was formerly known as Anglo Australia... Astral Resources NL engages in the exploration and evaluation of gold properties in Western Australia. The company’s flagship property is the 100% owned Mandilla Gold project located in the northern Widgiemooltha greenstone belt in Western Australia. The company was formerly known as Anglo Australian Resources NL and changed its name to Astral Resources NL in April 2022. Astral Resources NL was incorporated in 1985 and is based in South Perth, Australia. 詳細を表示

セクター

Materials

業界

Mining

ウェブサイト

astralresources.com.au

本社

South Perth, Australia

設立

1985

Astral Resources NL is listed in the Materials sector of the オーストラリア証券取引所 with ticker AARO. The last closing price for Astral Resources NL was AUD0.08. Over the last year, Astral Resources NL shares have traded in a share price range of AUD 0.00 to AUD 0.00.

Astral Resources NL currently has 1,801,045,606 shares in issue. The market capitalisation of Astral Resources NL is AUD145.88 million. Astral Resources NL has a price to earnings ratio (PE ratio) of -61.70.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

AARO - Frequently Asked Questions (FAQ)

What is the current Astral Resources NL share price?

The current share price of Astral Resources NL is AUD 0.081

How many Astral Resources NL shares are in issue?

Astral Resources NL has 1,801,045,606 shares in issue

What is the market cap of Astral Resources NL?

The market capitalisation of Astral Resources NL is AUD 145.88M

What is the 1 year trading range for Astral Resources NL share price?

Astral Resources NL has traded in the range of AUD 0.00 to AUD 0.00 during the past year

What is the PE ratio of Astral Resources NL?

The price to earnings ratio of Astral Resources NL is -61.7

What is the registered address of Astral Resources NL?

The registered address for Astral Resources NL is 6 Lyall Street, South Perth, Western Australia, 6151

What is the Astral Resources NL website address?

The website address for Astral Resources NL is astralresources.com.au

Which industry sector does Astral Resources NL operate in?

Astral Resources NL operates in the Mining sector

knrorrel

knrorrel 10分前

$PAVS WEEEEEEEEEEEEEEEEEEEEEEEE 🚀🚀🚀🚀🔥🔥🔥🔥🔥🔥🔥🔥🚀

knrorrel

knrorrel 17分前

PAVS and HKIT HKIT too , both should run hard today. 🔥
imho

10thMountain

10thMountain 31分前

Woohoo! I’m loving being an early investor. I’ve owned Fidelity Contra Fund for many years which holds a 5% stake in pre-IPO shares! Any other FCNTX holders here? If so…did you see the CNBC article out today that mentions FCNTX??

TieetCoolee

TieetCoolee 33分前

I am pleased to announce the Nomination of very Highly Respected Jay Clayton, former Chairman of the Securities and Exchange Commission, the former Head of Sullivan & Cromwell, one of the most prominent and successful Law Firms anywhere in the World, and the current United States Attorney for the So

PC retired

PC retired 34分前

I am somewhat surprised that there has been no action from the authorities on this scam, yet. The other scam that I have been following and hopefully helping to expose is the Astra/Holcomb(also on ADVFN) where an FBI raid was carried out ~1year ago and the FBI are actively looking for scammed invest

10thMountain

10thMountain 35分前

10thMountain

10thMountain 35分前

10thMountain

10thMountain 36分前

EMBR Is a very RARE gem. X is going crazy of it. Here’s another X post…

https://x.com/beardtrader1178/status/2065313802606760085?s=46

10thMountain

10thMountain 36分前

EMBR Is a very RARE gem. X is going crazy of it. Here’s another X post…

https://x.com/beardtrader1178/status/2065313802606760085?s=46

CA Market News

CA Market News 43分前

Vertical Data and Quantum eMotion Partner to Bring Quantum Cybersecurity to AI Infrastructure DeploymentsJune 12, 2026 3:00 AM
Newsfile

WALL STREET KID

WALL STREET KID 54分前

$AMC GREAT NEWS! $65 SHORT TERM TARGET!

https://youtu.be/POTxAjR9zXw?si=MhP3WfvvBEVYXiFO

https://x.com/CEOAdam/status/2065056828661080534

CA Market News

CA Market News 58分前

Vertical Data and Quantum eMotion Partner to Bring Quantum Cybersecurity to AI Infrastructure DeploymentsJune 12, 2026 3:00 AM
ACCESS NewswireInitial Pilot Deployment Targeted for 2026 Across Vertical Data's GPU Cluster and Edge Data Center Pipeline

US Market News

US Market News 58分前

AbbVie Presents New Data at EHA 2026 Congress for VENCLEXTA®/VENCLYXTO® (venetoclax) in First-Line Chronic Lymphocytic Leukemia Highlighting Long-Term Treatment Outcomes for Patients: Nine-Year ResultsJune 12, 2026 3:00 AM
PR Newswire (US) class="legen

US Market News

US Market News 58分前

AbbVie Presents New Data at EHA 2026 Congress for VENCLEXTA®/VENCLYXTO® (venetoclax) in First-Line Chronic Lymphocytic Leukemia Highlighting Long-Term Treatment Outcomes for Patients: Nine-Year ResultsJune 12, 2026 3:00 AM
PR Newswire (US) class="legen

sharkey1

sharkey1 1時間前

So we wait a year, or Accord scores the patent and Elite gets Tentative approval
then things might change .

iHub News

iHub News 1時間前

SpaceX Secures $75 Billion Ahead of Historic Market DebutJune 12, 2026 2:45 AM
IH Market News SpaceX (NASDAQ:

sharkey1

sharkey1 1時間前

THX, very confusing,
google says
None of these products have yet been approved by the FDA, and Elite therefore does not yet market any products. Elite Labs also engages in contract research ...Read more

no harm no foul
If they went to trial now, it would probly t

Libertas

Libertas 1時間前

Thanks for sharing that, too bad most will write it off as nonsense.

🐻

IH Admin [Shelly]

IH Admin [Shelly] 1時間前

Looks like your computer tried to login you in with your gmail account and it accidentally created a new alias.

Nightdaytrader

Nightdaytrader 1時間前

Split T, next Friday is federal holiday and I believe markets are closed.

Nd9

God Bless America

God Bless America 2時間前

Here I am. From 44 in 2008 to 62 now. So frustrated !

Split T

Split T 2時間前

Just a friendly reminder that next Fiday June 19th is Quadruple. Witching Day, IMVHO we are going to see some crazy trading next week and due to the latest news I'm thinking we will be over $15.30 at close next Friday with volume in excess of 8 million shares according to my William Allen Getty.

God Bless America

God Bless America 2時間前

No IPO for FNMA, FMCC. Just relist and do Second Public Offering.

God Bless America

God Bless America 2時間前

No IPO for FNMA, FMCC. Just relist and do Second Public Offering

Astral Resources NL

Critical Resources

Intelgenx Technologies

Horizons Active Emerging...

Pure Extracts Technologies

Fidelity Nasdaq Composite

BlockQuarry (ID)

Ls 3x Long South Korea Etp

Sunrise Energy Metals (QX)

Ubs Etfs Plc - Map Bal 7...

Goldstorm Metals

Agf Canadian Dividend In...

Mindmaze Therapeutics (QB)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。